For: | Lay CS, May C, Lee FY, Tsai YT, Lee SD, Chien S, Sinchon S. Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: Role of prostaglandin. World J Gastroenterol 2006; 12(15): 2351-2356 [PMID: 16688824 DOI: 10.3748/wjg.v12.i15.2351] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i15/2351.htm |
Number | Citing Articles |
1 |
Karol Kramkowski, Agnieszka Leszczynska, Wlodzimierz Buczko. Pharmacological modulation of fibrinolytic response – In vivo and in vitro studies. Pharmacological Reports 2015; 67(4): 695 doi: 10.1016/j.pharep.2015.05.022
|
2 |
Ying Yang, Jian Qiao, Huiyu Wang, Mingyu Gao, Deyuan Ou, Jianjun Zhang, Maohong Sun, Xin Yang, Xiaobo Zhang, Yuming Guo. Calcium antagonist verapamil prevented pulmonary arterial hypertension in broilers with ascites by arresting pulmonary vascular remodeling. European Journal of Pharmacology 2007; 561(1-3): 137 doi: 10.1016/j.ejphar.2007.01.036
|
3 |
Sotiria Bexis, P. Aiden McCormick, James R. Docherty. Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat. European Journal of Pharmacology 2008; 590(1-3): 322 doi: 10.1016/j.ejphar.2008.06.006
|
4 |
T Ohyama, K Sato, K Kishimoto, Y Yamazaki, N Horiguchi, T Ichikawa, S Kakizaki, H Takagi, T Izumi, M Mori. Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence. British Journal of Pharmacology 2012; 165(4b): 1173 doi: 10.1111/j.1476-5381.2011.01599.x
|